EVALUATION OF NK CELLS IN CHRONIC MYELOID LEUKEMIA PATIENTS: CORRELATION WITH RESPONSE TO TREATMENT

EHA Library, Immacolata Attolico, 215986

IMATINIB RESPONSE AND MICRORNAS PROFILE IN CML – A BIOMARKER FOR DRUG RESPONSE

EHA Library, Ana Bela Sarmento-Ribeiro, 215987

TWELVE YEARS RESULTS OF FIRST-PHASE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT WITH IMATINIB 400 MG (IMATIB *) IN 222 PATIENTS.

EHA Library, Naima Abdennebi, 215988

CHRONIC MYELOID LEUKEMIA (CML) MAY CO-EXPRESS THE P210 BCR-ABL1 AND P195 BCR-ABL1

EHA Library, Susana Gonçalves Pereira, 215989

BOSUTINIB VS IMATINIB FOR NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: LEARNINGS FROM 2 PHASE 3 TRIALS (BFORE AND BELA) CONDUCTED IN DIFFERENT ERAS

EHA Library, Michael Deininger, 215990

CIRCULATING INFLAMMA-MIRNAS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Antonella Poloni, 215991

HIF-1A EXPRESSION IS ASSOCIATED WITH PRIMARY RESISTANCE TO AZACITIDINE IN MDS PATIENTS – DATA FROM THE HELLENIC MDS STUDY GROUP

EHA Library, Vassiliki Pappa, 215992

HLA-G GENE AND PROTEIN EXPRESSION IN PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROME

EHA Library, Stavroula Giannouli, 215993

DIAGNOSTIC POTENTIAL OF ALDEHYDE DEHYDROGENASES ISOENZYMES IN MDS AND AML

EHA Library, Ana Bela Sarmento Ribeiro, 215995

THE 5 - AZACITIDINE THERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Hortensia Ionita, 215996

RISK-MITIGATION PLANS TO REDUCE INCIDENCE OF URINARY ADVERSE EVENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH ORAL RIGOSERTIB (RIGO) IN COMBINATION WITH AZACITIDINE (AZA).

EHA Library, Shyamala C. Navada, 215997

SOLUBLE ADHESION MOLECULE LEVELS PREDICT RESPONSE TO AZACYTIDINE IN PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROME – RESULTS OF A PIVOTAL TRIAL.

EHA Library, Jan M Horacek, 215998

THE ROLE OF FLT3-ITD MUTATION ON DE NOVO MDS AMONG CHINESE POPULATION

EHA Library, Shengli Xue, 215999

AZACITIDINE CAN INDUCE LIFE-THREATENING SKIN LESIONS

EHA Library, Camilla Vo, 216000

CHRONIC MYELOMONOCYTIC LEUKAEMIA A RETROSPECTIVE STUDY FROM A SINGLE CENTRE IN ROMANIA

EHA Library, Aurelia Tatic, 216001

A CASE OF SEVERE CONGENITAL NEUTROPENIA CARRYING A NOVEL HOMOZYGOUS MUTATION IN CSF3R GENE

EHA Library, Umran Caliskan, 216002

IMMUNOLOGICAL STATUS OF PATIENTS WITH DIAMOND BLACKFAN ANEMIA

EHA Library, Fatma Gumruk, 216003

CHROMOSOME FRAGILE SITE 16B AND BENIGN NEUTROPENIA: A FAMILIAR CASE STUDY

EHA Library, Nicola Stefano Fracchiolla, 216004

EPIDEMIOLOGY OF MULTIPLE MYELOMA IN A LARGE METROPOLITAN AREA OF RUSSIA (NOVOSIBIRSK)

EHA Library, Natalia Skvortsova, 216005

THE OCCURRENCE AND ECONOMIC BURDEN OF TREATMENT-INDUCED PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA IN SWEDEN

EHA Library, Hareth Nahi, 216006

FIRST-LINE THERAPY WITH BENDAMUSTINE/PREDNISONE/BORTEZOMIB (BPV) FOR NON-TRANSPLANT ELIGIBLE SYMPTOMATIC MULTIPLE MYELOMA PATIENTS

EHA Library, Wolfgang Knauf, 216008

NON-MYELOMA KIDNEY DISEASE AND MANAGEMENT ALGORITHM IN MYELOMA PATIENTS

EHA Library, Katy Westwood, 216009

COMPARISON OF TWO MOBILIZATION REGIMENS FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS.

EHA Library, Elena Mariggiò, 216010

OUTCOMES OF TREATMENT OF MULTIPLE MYELOMA IN PATIENTS REQUIRING RENAL REPLACEMENT THERAPY: “REAL WORLD” SINGLE CENTRE EXPERIENCE OVER AN 11 YEAR PERIOD

EHA Library, Aruni Ratnayake, 216011

PHASE III (IMROZ) STUDY DESIGN: ISATUXIMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (VRD) VERSUS VRD IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.

EHA Library, Thierry Facon, 216012

PHASE III (IKEMA) STUDY DESIGN: ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE (KD) VS KD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM).

EHA Library, Thomas Martin, 216013

THE TREATMENT WITH PEGYLATED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE AND DEXAMETHASINE (CED) FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Hortensia Ionita, 216014

REAL-WORLD EVIDENCE OF THE USE OF CARFILZOMIB AMONG PATIENTS WITH RELAPSED MULTIPLE MYELOMA IN EUROPE: AN INTERIM ANALYSIS FROM A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Evangelos Terpos, 216015

LONG TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

EHA Library, Marina Silvia Parisi, 216016

THE CLINICAL SIGNIFICANCE OF THE IMMUNOPHENOTYPIC PROFILE OF TUMOR PLASMA CELLS IN THE BONE MARROW AND PERIPHERAL BLOOD IN MULTIPLE MYELOMA COMPLICATED BY PLASMACYTOMAS.

EHA Library, Kirill Belousov, 216017

UNINVOLVED IGA SUPPRESSION PREDICTS EVOLUTION TO SYMPTOMATIC MYELOMA IN CONTEMPORARY DIAGNOSED SMM; PRELIMINARY RESULTS

EHA Library, A. Koudouna, 216018

THE PROSPECTIVE INTERSECTORAL NATIONAL COHORT STUDY MYRIAM TO STUDY CHARACTERISTICS, TREATMENT AND OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA IN GERMANY

EHA Library, Wolfgang Knauf, 216019

BORTEZOMIB INDUCTION AND MAINTENANCE THERAPY IN MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANTATION

EHA Library, Kameliya Milcheva, 216020

IMPACT OF NOVEL AGENTS ON AGGRESSIVE RELAPSE OF MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Enrica Martino, 216021

A MULTI-CENTER RETROSPECTIVE STUDY OF BONE DESTRUCTION ASSOCIATED WITH 419 NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Yanxia Jin, 216022

CARFILZOMIB AND DEXAMETHASONE VERSUS 8 CYCLES OF BORTEZOMIB AND DEXAMETHASONE: AN INDIRECT COMPARISON AND EXPLORATORY ANALYSIS OF THE EFFICACY AND SAFETY OF THE RANDOMIZED, PHASE 3 ENDEAVOR TRIAL

EHA Library, Katja Weisel, 216023

CHARACTERIZATION AND TREATMENT OUTCOME OF IGE MULTIPLE MYELOMA - A CASE SERIES.

EHA Library, Artur Jurczyszyn, 216024

TREATMENT WITH IXAZOMIB IN HEAVILY PRETREATED PATIENTS WITH MULTIPLE MYELOMA IN SLOVENIA: REAL LIFE DATA

EHA Library, Samo Zver, 216025

ASSESSMENT OF THE EFFICACY OF LOW-DOSE ASPIRIN BY THROMBOELASTOMETRY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA.

EHA Library, Emma Cacciola, 216026

HETEROGENEITY AMONG DIFFERENT MYELOPROLIFERATIVE NEOPLASMS ASSOCIATED WITH SPLANCHNIC VEIN THROMBOSIS

EHA Library, Daniele Cattaneo, 216027

HYDROXYUREA IN PH NEGATIVE MYELOPROLIFERATIVES NEOPLASMS (MPN): EXPERIENCE IN ARGENTINA

EHA Library, Miguel Castro Rios, 216028

ESSENTIAL THROMBOCYTHEMIA AND SECONDARY THROMBOCYTOSIS IN CHILDREN OF BELARUS

EHA Library, Tatiana Kozarezova, 216029

PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND CLINICAL OUTCOMES IN THE FRONTLINE TREATMENT OF ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA IN THE UNITED KINGDOM, FRANCE, AND GERMANY

EHA Library, Mehul Dalal, 216030

LONG-TERM FOLLOW-UP OF 2 PATIENTS TREATED WITH 90Y-RITUXIMAB RADIOIMMUNOTHERAPY FOR RELAPSE OF PREDOMINANTLY LYMPHOCYTIC NODULAR HODGKIN'S LYMPHOMA

EHA Library, Sophie Golstein, 216031

EFFICACY AND SAFETY OF HIGH DOSE BENDAMUSTINE PLUS BRENTUXIMAB VEDOTIN IN REFRACTORY OR RELAPSED CLASSICAL HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Marta Raimondo, 216032

PROGNOSTIC SCORES IN HODGKIN LYMPHOMA (HL): COMPARISON OF THE IPS AND THE GHSG SCORE IN AN UNIFORMLY TREATED COHORT

EHA Library, Margarida Fevereiro, 216033

ANTI-PD1 INHIBITOR FOLLOWED BY ALLO STEM CELL TRANSPLANTATION IN 6 HEAVELY PRETREATED LYMPHOMA’S PATIENTS : EXPERIENCE OF JULES BORDET INSTITUTE

EHA Library, Adriano Salaroli, 216034

MULTICENTRE STUDY OF QUANTITATIVE PET VALUES IN PRIMARY PATIENTS WITH HODGKIN LYMPHOMA (HL): UPDATE RESULTS

EHA Library, Iryna Kriachok, 216035

LOW CONCENTRATION OF VENETOCLAX INDUCES APOPTOSIS OF HIGH-GRADE B-CELL LYMPHOMA CELLS

EHA Library, Akiko Uchida, 216036

NOVEL THIENOPYRIDINES AS POTENT INDUCERS OF CELL CYCLE ARREST IN MATURE B-CELL NEOPLASMS

EHA Library, Christopher Broughton, 216037

HISTOLOGICAL AND MOLECULAR BONE MARROW INVOLVEMENT IN FOLLICULAR LYMPHOMA 3 GRADE

EHA Library, Lyubov V. Plastinina, 216038

FUNCTIONAL SCREEN FOR 177LU-LILOTOMAB SATETRAXETAN DRUG COMBINATIONS FOR TREATMENT OF AGGRESSIVE DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Sebastian Patzke, 216039

STRONG PD-1 EXPRESSION ON TUMOR-INFILTRATING T-CELLS IN DIFFUSE LARGE B CELL AND FOLLICULAR LYMPHOMA.

EHA Library, Silvia Bellesi, 216040

CASTLEMAN DISEASE WITH THE EXPERIENCE OVER 17 YEARS

EHA Library, Guray Saydam, 216041

EFFICACY OF RITUXIMAB PLUS BENDAMUSTINE REGIMEN AS FIRST OR SECOND LINE TREATMENT IN WALDENSTRÖM’S MACROGLOBULINAEMIA.

EHA Library, Francois-Xavier Gros, 216042

FCƔ RECEPTOR SNP CAN BE A PREDICTOR OF EFFICIENCY OF TARGET THERAPY OF NON-HODGKIN'S MALIGNANT LYMPHOMAS IN RUSSIAN POPULATION

EHA Library, Viktor Ovchinnikov, 216043

THE ROLE OF 18F-FDG PET/CT IN THE DIAGNOSIS AND FOLLOW-UP OF GASTRIC LYMPHOMA: A MONOCENTER EXPERIENCE.

EHA Library, Fabiana Cacace, 216044

CONTRIBUTION OF FLOW CYTOMETRY BY FINE NEEDLE ASPIRATION COUPLED WITH CYTOLOGY IN THE DIAGNOSIS AND CLASSIFICATION OF SMALL-CELL NHL B AND ITS CORRELATION WITH HISTOLOGY AND IMMUNOHISTOCHEMISTRY

EHA Library, Abbadi Mohamed Rafik, 216045

CUTANEOUS MANIFESTATIONS OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Natalia Chernova, 216046

IMMUNOGLOBULINOPATHIES IN PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Natalia Chernova, 216047

ACQUIRED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AMONG HEMATOLOGIC PATIENTS: A SINGLE CENTRE EXPERIENCE

EHA Library, Nicola Stefano Fracchiolla, 216048

MANAGEMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (MCL) IN ROUTINE CLINICAL PRACTICE IN SPAIN (IMORS STUDY). DESCRIPTIVE DATA AND EFFICACY RESULTS

EHA Library, Reyes Arranz, 216049

PRIMARY CNS LYMPHOMA: SINGLE INSTITUTION EXPERIENCE WITH THE 2015 GELTAMO PROTOCOL

EHA Library, CAROLINA CAÑIGRAL, 216050

MEDIASTINAL GREY ZONE LYMPHOMA

EHA Library, Yana Mangasarova, 216051

PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA AND EXTRAMEDIASTINAL LESION

EHA Library, Yana Mangasarova, 216052

COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Haluk Demiroğlu, 216053

IMPACT OF AB0 INCOMPATIBILITY ON ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Francesco Onida, 216054

PROGNOSTIC IMPACT OF MINIMAL RESIDUAL DISEASE IN AML PATIENTS BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION ON DISEASE FREE SURVIVAL

EHA Library, Olga Koroleva, 216055

HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN HIGH-RISK HEMATOLOGICAL MALIGNANCIES WITH COMBINATION OF UNMANIPULATED BONE MARROW AND PERIPHERAL BLOOD STEM CELLS.

EHA Library, Dina Ait Ouali, 216056

BEAC (CARMUSTINE, ETOPOSIDE, CYTARABINE, AND CYCLOPHOSPHAMIDE) IS A SAFE AND EFFECTIVE CONDITIONING REGIMEN IN AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR LYMPHOMA

EHA Library, Ioanna Sakellari, 216057

INFLUENCE OF LENALIDOMIDE USED IN INDUCTION PERIOD AND INTENSITY OF MOBILIZATION REGIMEN ON THE NUMBER OF CD34+ CELLS HARVESTED IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Ivan Kostroma, 216058

HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGH RISK HEMATOLOGIC MALIGNANCIES: RISK FACTOR AND OUTCOME ANALYSES IN OUR CENTER

EHA Library, María Perera Alvarez, 216059

HAPLOIDENTICAL TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN ADULT PATIENTS WITH HEMOBLASTOSES IN THE REPUBLIC OF KAZAKHSTAN

EHA Library, Anastassiya Olifirovich, 216060

DESIGN OF PHASE 3, RANDOMIZED TRIAL OF DEFIBROTIDE FOR PREVENTION OF HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME

EHA Library, Stephan Grupp, 216061

IMPACT OF PROCALCITONIN IN THE DIFFERENTIAL DIAGNOSIS OF FEBRILE COMPLICATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Benedetto Bruno, 216062

TREATMENTS FOR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Aliki Taylor, 216063

OVERALL SURVIVAL AND NON-RELAPSE MORTALITY OF PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Thomas Webb, 216064

RELATIONSHIP BETWEEN THE CONTENT OF CD34 + CELLS AND THEIR COLONY-FORMING CAPACITY IN PATIENTS WITH MULTIPLE MYELOMA IN THE PROCESS OF PREPARING A LEUKAPERESIS PRODUCT FOR AUTOLOGOUS TRANSPLANTATION

EHA Library, Jeanna Chubukina, 216065

CYTARABINE IS MORE EFFECTIVE THAN CYCLOPHOSPHAMIDE AS A STEM CELL MOBILIZATION REGIMEN IN MULTIPLE MYELOMA

EHA Library, Tomáš Jelínek, 216066

CLINICAL RESPONSE TO SYSTEMIC TREATMENTS FOR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Thomas Webb, 216067

GLYCERYL TRINITRATE FOR THE TREATMENT OF SICKLE CELL LEG ULCERS

EHA Library, Pablo Bartolucci, 216068

IMPACT OF SICKLE CELL DISEASE ON WORK, SCHOOL, RELATIONSHIPS, AND SOCIAL LIFE: RESULTS FROM IN-DEPTH INTERVIEWS WITH PATIENTS

EHA Library, Miranda Bailey, 216069

BARRIERS TO TREATMENT FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM IN-DEPTH INTERVIEWS WITH PATIENTS AND CAREGIVERS

EHA Library, Miranda Bailey, 216070

DISTRIBUTION OF IL4 VNTR POLYMORPHISMS AMONG SUDANESE PATIENTS WITH SICKLE CELL DIEASE

EHA Library, Tyseer Alabid, 216071

HEMOGLOBINOPATHIES SCREENING IN A EUROPEAN CENTRAL HOSPITAL- RETROSPECTIVE STUDY OF THE LAST 10 YEARS

EHA Library, Catarina Sousa Neves, 216072

A FEW WORDS ABOUT APLASTIC ANEMIA IN ARMENIA

EHA Library, Smbat Daghbashyan, 216073

THE PEAK REGISTRY, A GLOBAL LONGITUDINAL OBSERVATIONAL STUDY OF PATIENTS WITH PYRUVATE KINASE DEFICIENCY

EHA Library, Bryan Jones, 216074

SOLUBLE TRANSFERRIN RECEPTOR LEVEL AS PREDICTOR OF IRON OVERLOAD IN PATIENTS WITH Β-THALASSEMIA AND SICKLE CELL DISEASE

EHA Library, Amal El-Beshlawy, 216075

INFECTIOUS COMPLICATIONS IN FIRST THREE CYCLES OF AZACITIDINE DID NOT NEGATIVELY IMPACT OVERALL SURVIVAL OF MYELODYSPLASTIC SYNDROME PATIENTS

EHA Library, Zhi Xuan Ng, 216076

PRIMARY PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: RESULTS FROM A SINGLE-CENTRE STUDY

EHA Library, Nicola Stefano Fracchiolla, 216077

ACUTE HEPATITIS E OCCURRING IN ONCOHEMATOLOGIC PATIENTS: A SINGLE CENTRE EXPERIENCE

EHA Library, Nicola Stefano Fracchiolla, 216078

PRIMARY ANTIFUNGAL PROPHYLAXIS WITH MICAFUNGIN IN HEMATOLOGICAL MALIGNANCIES: A SINGLE CENTER EXPERIENCE.

EHA Library, Marika Porrazzo, 216079

ANALYSIS OF INFECTIONS AND USE OF ANTIMICROBIALS IN PATIENTS UNDER-GOING INTENSIVE INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Ane Aranbarri Larrañaga, 216080

CLINICAL AND LABORATORY FEATURES OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH B-CELL LYMPHOMA

EHA Library, Nikolai Klimko, 216081

SALVAGING DISSEMINATED CUTANEOUS MUCORMYCOSIS WITH TRIPLE ANTI-FUNGAL THERAPY PLUS GRANULOCYTE INFUSION

EHA Library, Khushnuma Mullanfiroze, 216082

CLASSICAL OR ALTERNATIVE COMPLEMENT PATHWAY INHIBITION ALONE DOES NOT PREVENT WHOLE BLOOD KILLING OF ANTIBODY-COATED N. MENINGITIDIS OR S. PNEUMONIAE

EHA Library, Graham C. Parry, 216083

RISK FACTORS ASSOCIATED TO MORTALITY IN PATIENTS WITH HEMOPATHIES REQUIRING ENTRY IN THE INTENSIVE CARE UNIT

EHA Library, Estefania Morente Constantin, 216084

DARATUMUMAB AND BLOOD-COMPATIBILITY TESTING: EXPERIENCE IN OUR CENTER

EHA Library, ALMUDENA GARCIA RUIZ, 216085

EVALUATION OF PLATELET RECEPTOR EXPRESSION IN CHRONIC LYMPHOID LEUKEMIA TREATED WITH IBRUTINIB

EHA Library, Horia Bumbea, 216086

ACCURACY EVALUATION OF LOW PLATELET COUNTS ON A NOVEL SLIDE-BASED INTEGRATED HEMATOLOGY ANALYZER

EHA Library, Vincent H.J. van der Velden, 216087